Neuroleptics (antipsychotics) In 1973, psychiatrist George Crane gained the attention of the medical community by disclosing that many, and perhaps most, long-term neuroleptic patients were developing a largely irreversible, untreatable neurological disorder, tardive dyskinesia. The disease, even its mild forms, is often disfiguring, with involuntary movements of the face, mouth […]
RECENT FDA DECISION HIGHLIGHTS ETHICAL ISSUES IN DRUG RESEARCH ON CHILDREN by Peter R. Breggin, M.D. April 21, 1998 The FDA has put the interests of drug companies and the psychiatric research establishment ahead of those of America’s children. It is time for the public and concerned professionals to […]
Benzodiazepines Collection of scientific papers by Dr. Breggin on benzodiazepines or tranquilizers and sleeping pills Analysis of adverse behavioral effects of benzodiazepines (tranquilizers) (PDF) Chapter from Brain-Disabling Treatments in Psychiatry on benzodiazepines Chapter from Brain-Disabling Treatments in Psychiatry on benzodiazepines Books by Dr. Breggin that deal with the effects […]
Psycho-stimulants Millions of children in North America are diagnosed with attention deficit/hyperactivity disorder and treated with pyschostimulants such as methylphenidate, dextroamphetamine, and methamphetamine. These drugs produce a continuum of central nervous system toxicity that begins with increased energy, hyperalertness, and overfocusing on rote activities. It progresses toward obsessive compulsive or […]
psychostimulantsin.pbreggin.1999.pdf
Brain Development Continues Throughout Teen Years A recent study in the Journal of the American Medical Association pointed out the danger of the escalating use of psychiatric medication in the treatment of two-to-four year olds. Editorials in the journal, as well as in the Washington Post and USA Today, […]
spearheadingatransformation.pbreggin.1996.pdf
empoweringsocial.pbreggin.2001.pdf
campaignsagainst.pbreggin.1995.pdf
Electroshockscientific.pbreggin.1998.pdf
